Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhea N Coler

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|September 17, 2024
Antibodies as key mediators of protection against <i>Mycobacterium tuberculosis</i>Qixin Wang, Deepika Nag, Susan L Baldwin, et al.
Vaccine|September 7, 2007
Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvantYasuyuki Goto, Lisa Y Bogatzki, Sylvie Bertholet, et al.
Frontiers in Immunology|April 1, 2022
It Takes a Village: The Multifaceted Immune Response to <i>Mycobacterium tuberculosis</i> Infection and Vaccine-Induced ImmunitySasha E Larsen, Brittany D Williams, Maham Rais, et al.
AIMS Microbiology|April 24, 2023
SARS-CoV-2 infection and immune responsesRakhi Harne, Brittany Williams, Hazem F M Abdelal, et al.
Microorganisms|July 27, 2022
<i>Mycobacterium abscessus</i>: It's ComplexHazem F M Abdelaal, Edward D Chan, Lisa Young, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2012
The importance of adjuvant formulation in the development of a tuberculosis vaccineSusan L Baldwin, Sylvie Bertholet, Valerie A Reese, et al.
Vaccine|December 8, 2010
Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsionsSusan L Baldwin, Christopher B Fox, Mark A Pallansch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2015
Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic MechanismRhea N Coler, Thomas Hudson, Sean Hughes, et al.
Tuberculosis (Edinburgh, Scotland)|January 11, 2011
Mycobacterium tuberculosis Rv0198c, a putative matrix metalloprotease is involved in pathogenicityD G Niranjala Muttucumaru, Debbie A Smith, Elizabeth J McMinn, et al.
Clinical and Vaccine Immunology : CVI|July 18, 2014
The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivativeSusan L Baldwin, Valerie Reese, Brian Granger, et al.
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|September 17, 2024
Antibodies as key mediators of protection against <i>Mycobacterium tuberculosis</i>Qixin Wang, Deepika Nag, Susan L Baldwin, et al.
Vaccine|September 7, 2007
Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvantYasuyuki Goto, Lisa Y Bogatzki, Sylvie Bertholet, et al.
Frontiers in Immunology|April 1, 2022
It Takes a Village: The Multifaceted Immune Response to <i>Mycobacterium tuberculosis</i> Infection and Vaccine-Induced ImmunitySasha E Larsen, Brittany D Williams, Maham Rais, et al.
AIMS Microbiology|April 24, 2023
SARS-CoV-2 infection and immune responsesRakhi Harne, Brittany Williams, Hazem F M Abdelal, et al.
Microorganisms|July 27, 2022
<i>Mycobacterium abscessus</i>: It's ComplexHazem F M Abdelaal, Edward D Chan, Lisa Young, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2012
The importance of adjuvant formulation in the development of a tuberculosis vaccineSusan L Baldwin, Sylvie Bertholet, Valerie A Reese, et al.
Vaccine|December 8, 2010
Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsionsSusan L Baldwin, Christopher B Fox, Mark A Pallansch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2015
Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic MechanismRhea N Coler, Thomas Hudson, Sean Hughes, et al.
Tuberculosis (Edinburgh, Scotland)|January 11, 2011
Mycobacterium tuberculosis Rv0198c, a putative matrix metalloprotease is involved in pathogenicityD G Niranjala Muttucumaru, Debbie A Smith, Elizabeth J McMinn, et al.
Clinical and Vaccine Immunology : CVI|July 18, 2014
The ID93 tuberculosis vaccine candidate does not induce sensitivity to purified protein derivativeSusan L Baldwin, Valerie Reese, Brian Granger, et al.
Pageof 14